Humoral response to SARS-CoV-2 COVID-19 vaccines in patients with multiple sclerosis treated with immune reconstitution therapies

BACKGROUND: It has been generally accepted that people with MS (PwMS) should be vaccinated against COVID-19. The aim of our investigation was to evaluate the humoral response to natural SARS-CoV-2 infection and to two COVID-19 vaccines (BNT162b2 Pfizer-BioNTech and Beijing/Sinopharm BBIBP-CorV) in o...

Descripción completa

Detalles Bibliográficos
Autores principales: Drulovic, Jelena, Ivanovic, Jovana, Martinovic, Vanja, Tamas, Olivera, Veselinovic, Nikola, Cujic, Danica, Gnjatovic, Marija, Mesaros, Sarlota, Pekmezovic, Tatjana
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Author(s). Published by Elsevier B.V. 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8280377/
https://www.ncbi.nlm.nih.gov/pubmed/34298478
http://dx.doi.org/10.1016/j.msard.2021.103150

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8280377/
https://www.ncbi.nlm.nih.gov/pubmed/34298478
http://dx.doi.org/10.1016/j.msard.2021.103150

Ejemplares similares